114 related articles for article (PubMed ID: 35714314)
1. Identification of RCC1-LCK as a novel fusion gene in pediatric erythroid sarcoma.
Oya S; Osone S; Yoshida M; Nishimoto S; Taura Y; Yoshida H; Miyachi M; Inaba T; Konishi E; Kato M; Imamura T; Iehara T
Pediatr Blood Cancer; 2022 Sep; 69(9):e29848. PubMed ID: 35714314
[TBL] [Abstract][Full Text] [Related]
2. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1.
Li L; Cui Y; Shen J; Dobson H; Sun G
Leuk Res; 2019 Mar; 78():12-20. PubMed ID: 30660961
[TBL] [Abstract][Full Text] [Related]
3. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
[TBL] [Abstract][Full Text] [Related]
4. Isolated Mediastinal Myeloid Sarcoma after
Tüfekçi Ö; Yılmaz Ş; Erdem M; Baysal B; Ören H
Turk J Haematol; 2019 Nov; 36(4):285-286. PubMed ID: 30859798
[No Abstract] [Full Text] [Related]
5. Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation.
Vahedi S; Chueh FY; Chandran B; Yu CL
BMC Cancer; 2015 Jul; 15():551. PubMed ID: 26210498
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.
Choschzick M; Bacher U; Ayuk F; Lebeau A
J Clin Pathol; 2010 Jun; 63(6):558-61. PubMed ID: 20360144
[TBL] [Abstract][Full Text] [Related]
7. The herpesvirus saimiri tip484 and tip488 proteins both stimulate lck tyrosine protein kinase activity in vivo and in vitro.
Kjellen P; Amdjadi K; Lund TC; Medveczky PG; Sefton BM
Virology; 2002 Jun; 297(2):281-8. PubMed ID: 12083826
[TBL] [Abstract][Full Text] [Related]
8. Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia.
Scholl S; Lüftner J; Mügge LO; Schmidt V; Fricke HJ; Höffken K
Ann Hematol; 2007 Oct; 86(10):763-5. PubMed ID: 17639390
[No Abstract] [Full Text] [Related]
9. Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract][Full Text] [Related]
10. Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
Naesens L; Devos H; Nollet F; Michaux L; Selleslag D
Acta Haematol; 2018; 140(2):97-104. PubMed ID: 30227397
[TBL] [Abstract][Full Text] [Related]
11. Targets of p56(lck) activity in immature thymoblasts: stimulation of the Ras/Raf/MAPK pathway.
Lin K; Abraham KM
Int Immunol; 1997 Feb; 9(2):291-306. PubMed ID: 9040011
[TBL] [Abstract][Full Text] [Related]
12. Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor.
Zhou J; Xiao Z; Zhan Y; Qu X; Mou S; Deng C; Zhang T; Lan X; Huang S; Li Y
Front Immunol; 2021; 12():656366. PubMed ID: 34149695
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis.
Zhao Y; Zhang X; Zhao Y; Kong D; Qin F; Sun J; Dong Y
Med Oncol; 2015 May; 32(5):152. PubMed ID: 25832863
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.
Park KU; Lee DS; Lee HS; Kim CJ; Cho HI
Am J Pathol; 2001 Dec; 159(6):2011-6. PubMed ID: 11733351
[TBL] [Abstract][Full Text] [Related]
15. Co-ordination of the expression of the protein tyrosine kinase p56(lck) with the pre-T cell receptor during thymocyte development.
Buckland J; Pennington DJ; Bruno L; Owen MJ
Eur J Immunol; 2000 Jan; 30(1):8-18. PubMed ID: 10602022
[TBL] [Abstract][Full Text] [Related]
16. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
[TBL] [Abstract][Full Text] [Related]
17. Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.
Betapudi V; Shukla M; Alluri R; Merkulov S; McCrae KR
FASEB J; 2016 Oct; 30(10):3515-3526. PubMed ID: 27402674
[TBL] [Abstract][Full Text] [Related]
18. Sustained spontaneous remission in KMT2A-MLLT3 mutated myeloid sarcoma.
Armstrong C; Au WY; Ma ESK; Wong SHM; Orfali N
Ann Hematol; 2023 May; 102(5):1271-1274. PubMed ID: 36930260
[No Abstract] [Full Text] [Related]
19. Biochemical analysis of interleukin-2 receptor beta chain phosphorylation by p56(lck).
Delespine-Carmagnat M; Bouvier G; Allée G; Fagard R; Bertoglio J
FEBS Lett; 1999 Mar; 447(2-3):241-6. PubMed ID: 10214954
[TBL] [Abstract][Full Text] [Related]
20. Do Not Forget the Glycophorin A: An Unusual Case of Myeloid Sarcoma.
Mohanlal RD; Vaughan J; Ramparsad N; Naidu G
J Pediatr Hematol Oncol; 2016 Jul; 38(5):e173-6. PubMed ID: 26907661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
